Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Nucleoside Metabolic Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CAPECITABINE 63,506 8,892 14.0% 17,529 2,289 61.8 yrs 65.1%
FLUOROURACIL 53,045 6,997 13.2% 20,941 3,794 62.0 yrs 44.2%
CYTARABINE 44,383 9,089 20.5% 17,861 4,851 38.0 yrs 41.2%
GEMCITABINE 31,328 5,142 16.4% 12,268 2,563 61.2 yrs 48.4%
FLUDARABINE 23,660 6,831 28.9% 6,745 2,122 39.8 yrs 39.7%
AZACITIDINE 19,323 6,641 34.4% 9,028 2,037 68.9 yrs 38.5%
MERCAPTOPURINE 11,490 1,468 12.8% 5,925 1,094 21.5 yrs 43.8%
DECITABINE 2,983 816 27.4% 1,060 229 56.2 yrs 43.2%
CLOFARABINE 1,419 528 37.2% 409 139 31.0 yrs 43.4%
NELARABINE 735 156 21.2% 265 113 29.3 yrs 30.1%

Head-to-Head Comparisons

CAPECITABINE vs FLUOROURACIL CAPECITABINE vs CYTARABINE CAPECITABINE vs GEMCITABINE CAPECITABINE vs FLUDARABINE FLUOROURACIL vs CYTARABINE FLUOROURACIL vs GEMCITABINE FLUOROURACIL vs FLUDARABINE CYTARABINE vs GEMCITABINE CYTARABINE vs FLUDARABINE GEMCITABINE vs FLUDARABINE
← Back to Nucleoside Metabolic Inhibitor [EPC] Class side effects →